Tanta University: COVID-19 trials

The registry lists 13 COVID-19 studies with Tanta University as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effect of COVID-19 Infection on Obstertric Complications and Maternal OutcomesCompletedNCT06557694
• Relation Between Atherogenic Index of COVID-19 and Upcoming Cardiac Morbidity and Mortality in Non-Cardiac PatientsCompletedNCT05226377
• Dexmedetomidine Reduces Atrial Fibrillation in Mechanically Ventilated Patients With COVID-19 PneumoniaStatus unknownNCT05171985Not applicable
• Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's PatientsStatus unknownNCT04583566
• The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 PatientsCompletedNCT04560530
• IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian PatientsCompletedNCT04544033
• Ivermectin Nasal Spray for COVID19 PatientsStatus unknownNCT04510233Phase 2
• Sofosbuvir Containing Regimens in Treatment of COVID 19 PatientsStatus unknownNCT04497649Phase 2/3
• Safety and Efficacy of Tramadol in COVID-19 Egyptian PatientsStatus unknownNCT04454307Phase 1/2
• Isotretinoin in Treatment of COVID-19Status unknownNCT04361422Phase 3
• Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19Status unknownNCT04361318Phase 2/3
• Ivermectin and Nitazoxanide Combination Therapy for COVID-19Status unknownNCT04360356Phase 2/3
• Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 TreatmentCompletedNCT04353336Phase 2/3